Doyle Anthony 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed May 4, 2020
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2020-04-30+600,000→ 600,000 totalExercise: $3.91From: 2021-04-30Exp: 2020-04-30→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]Initial Employee Option Grant, 200,000 of which become exercisable on the first anniversary of the grant date or upon termination if, within the first year of his employment, Mr. Doyle is impacted by a reduction in force at the Company, and the remainder of which will vest in three equal installments on the second, third and fourth anniversaries of the grant date.